• Date: November 14, 2017

Back in 1991, 14 November was the date set by the International Diabetes Federation and the World Health Organisation for World Diabetes Day. The event is the largest campaign of its kind to raise awareness of the metabolic disease, and reaches over 1 billion people worldwide.


One of the objectives of CaixaImpulse is to promote research transfer to the market in order to improve people’s health. Diabetes is a several complex condition affecting the quality of life of many people worldwide. In general, diabetes patients are to some extent unable to control the amount of sugar levels in their blood, and this is the focus of most treatments. However, this treatment results in some patients developing fatty liver disease.


Finding a new treatment for diabetic patients with associated fatty liver disease is one of the objectives of the APODRUG project. The project took part in CaixaImpulse in 2016, and is led by scientists from the Center for Applied Medical Research (CIMA) at the University of Navarra.

More programme highlights

September 12, 2018

Pitch Day for CaixaImpulse 2017 projects

On 6 September, CaixaForum Barcelona hosted a Pitch Day for the projects that took part in the CaixaImpulse 2017.

September 07, 2018

CaixaImpulse guides 20 biomedical projects to take the step from the laboratory to the market

A diagnostic kit for septicaemia and a medical device to reduce hospital-acquired infections are some examples of the projects featured in the 2018 programme.

August 30, 2018

CaixaImpulse 2018 kicks off with the Immersion Week

From 3-7 September, CaixaImpulse will host the first of four weeks of training available to this year’s participants.